Novel Therapeutic Approaches to Autoimmune Demyelinating Disorders
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3191-3201
Author(s):
Lara Sanvito, Cris S. Constantinescu and Bruno Gran
A Structure-Function Perspective of Jak2 Mutations and Implications for Alternate Drug Design Strategies: The Road not Taken
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4659-4673
Author(s):
K. Gnanasambandan and P.P. Sayeski
Clinical Trial Update and Novel Therapeutic Approaches for Metastatic Prostate Cancer
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4440-4453
Author(s):
R. Larsson, N. P. Mongan, M. Johansson, L. Shcherbina, P.-A. Abrahamsson, L. J. Gudas, O. Sterner and J. L. Persson
The Coordinated Role of CYP450 Enzymes and P-gp in Determining Cancer Resistance to Chemotherapy
Journal:
Current Drug Metabolism
Volume:
12
Page:
713-721
Author(s):
Amalia Azzariti, Letizia Porcelli, Anna Elisa Quatrale, Nicola Silvestris and Angelo Paradiso
Future Prospects for Targeted Alpha Therapy
Journal:
Current Radiopharmaceuticals
Volume:
4
Page:
336-342
Author(s):
Barry J. Allen
Applications of 211At and 223Ra in Targeted Alpha-Particle Radiotherapy
Journal:
Current Radiopharmaceuticals
Volume:
4
Page:
283-294
Author(s):
Ganesan Vaidyanathan and Michael R. Zalutsky
Targeted Alpha Therapy with 213Bi
Journal:
Current Radiopharmaceuticals
Volume:
4
Page:
295-305
Author(s):
Alfred Morgenstern, Frank Bruchertseifer and Christos Apostolidis
New Strategies in the Discovery of Novel Non-Camptothecin Topoisomerase I Inhibitors
Journal:
Current Medicinal Chemistry
Volume:
18
Page:
4389-4409
Author(s):
Chunquan Sheng, Zhenyuan Miao and Wannian Zhang
Exploring and Exploiting Biologically Relevant Chemical Space
Journal:
Current Drug Targets
Volume:
12
Page:
1531-1546
Author(s):
Luc Eberhardt, Kamal Kumar and Herbert Waldmann
Perspectives on Sesquiterpene Lactones in Inflammation and Cancer
Journal:
Current Drug Targets
Volume:
12
Page:
1560-1573
Author(s):
Irmgard Merfort